KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Resmed (RMD) Non Operating Income (2016 - 2025)

Resmed (RMD) has disclosed Non Operating Income for 17 consecutive years, with $4.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non Operating Income rose 102.57% year-over-year to $4.5 million, compared with a TTM value of -$1.5 million through Dec 2025, up 79.41%, and an annual FY2025 reading of -$7.8 million, down 123.15% over the prior year.
  • Non Operating Income was $4.5 million for Q4 2025 at Resmed, up from $256000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $5.2 million in Q2 2021 and bottomed at -$16.8 million in Q3 2023.
  • Average Non Operating Income over 5 years is -$3.3 million, with a median of -$2.7 million recorded in 2024.
  • Peak annual rise in Non Operating Income hit 423.03% in 2024, while the deepest fall reached 4947.54% in 2024.
  • Year by year, Non Operating Income stood at $841000.0 in 2021, then crashed by 873.25% to -$6.5 million in 2022, then soared by 89.45% to -$686000.0 in 2023, then surged by 423.03% to $2.2 million in 2024, then surged by 102.57% to $4.5 million in 2025.
  • Business Quant data shows Non Operating Income for RMD at $4.5 million in Q4 2025, $256000.0 in Q3 2025, and -$2.1 million in Q2 2025.